Chromatin modifications and dynamics during repair of a double-strand chromosome break in budding yeast
Epigenetics & Chromatin 2013, 6(Suppl 1):O16 (18 March 2013)
The CaMKII/NMDAR complex as a molecular memory
Molecular Brain 2013, 6:10 (14 February 2013)
Open questions - in brief: Beyond -omics, missing motor proteins, and getting from molecules to organisms
BMC Biology 2013, 11:8 (31 January 2013)
Hypothesis-driven genomics pays off
Genome Biology 2012, 13:176 (30 October 2012)
Greg Petsko on deCode's rocky road to AD drug discovery
Performance measures for substance use disorders – what research is needed?
Addiction Science & Clinical Practice 2012, 7:18 (11 September 2012)
Characteristics of practitioners in a private managed behavioral health plan
BMC Health Services Research 2012, 12:283 (28 August 2012)
A corpus of full-text journal articles is a robust evaluation tool for revealing differences in performance of biomedical natural language processing tools
BMC Bioinformatics 2012, 13:207 (17 August 2012)
Unintended consequences of cigarette price changes for alcohol drinking behaviors across age groups: evidence from pooled cross sections
Substance Abuse Treatment, Prevention, and Policy 2012, 7:28 (11 July 2012)
Out of Africa
Genome Biology 2012, 13:162 (29 June 2012)
Greg Petsko suggests five disreputable ways of making a fortune in science.
Genome Biology 2012, 13:155 (18 May 2012)
Guaranteeing experimental outcomes and findings: funding then and now
Online self-administered training for post-traumatic stress disorder treatment providers: design and methods for a randomized, prospective intervention study
Implementation Science 2012, 7:43 (14 May 2012)
BMC Biology 2012, 10:41 (11 May 2012)
The real topic of Gregory Petsko's Comment in our Metabolism diet and disease series is not, despite its title, mending walls, but patterns of comorbidity that argue for cross-disciplinary research: obesity and cancer are linked, for example, but apparently not if you are also schizophrenic.
Biotemplating rod-like viruses for the synthesis of copper nanorods and nanowires
Journal of Nanobiotechnology 2012, 10:18 (1 May 2012)
Economies of scale
Genome Biology 2012, 13:154 (30 April 2012)
The current glut of postdoctoral and graduate scientists can be addressed by applying economic principles.
Genome Biology 2012, 13:151 (30 March 2012)
Greg Petsko identifies some signs of the coming end of the world and, in that context, urges readers to pay close attention to the coming US presidential election
How much can we gain from improved efficiency? An examination of performance of national HIV/AIDS programs and its determinants in low- and middle-income countries
BMC Health Services Research 2012, 12:74 (24 March 2012)
Pattern and levels of spending allocated to HIV prevention programs in low- and middle-income countries
BMC Public Health 2012, 12:221 (21 March 2012)
A case of the flu
Genome Biology 2012, 13:146 (24 February 2012)
The public perception of science is a crucial factor in whether the availability of recent work on constructing a virulent strain of influenza should be restricted
The dog particle
Genome Biology 2012, 13:142 (30 January 2012)
In a big announcement suspiciously soon before their funding is renewed, canine researchers have news about the Briggs Noson
Substance abuse treatment client experience in an employed population: results of a client survey
Substance Abuse Treatment, Prevention, and Policy 2012, 7:4 (17 January 2012)
The Columnist Manifesto
Genome Biology 2011, 12:136 (28 December 2011)
Scientists need to explain to the public what science is and why it needs funding, especially when the economic situation is bad
Genome Biology 2011, 12:134 (30 November 2011)
If we fund the next big science program, how many smaller research programs will receive no funding as a consequence?
On universal common ancestry, sequence similarity, and phylogenetic structure: the sins of P-values and the virtues of Bayesian evidence
Biology Direct 2011, 6:60 (24 November 2011)
Douglas Theobald, in response to recent criticisms, provides evidence to further support his claim that Darwin's hypothesis that all life on earth has a universal common ancestor has been formally confirmed by a homology independent statistic test.
Genome Biology 2011, 12:131 (29 October 2011)
Let us shout to the public and private sectors, this is not the time to be bailing out
Chronic disease and recent addiction treatment utilization among alcohol and drug dependent adults
Substance Abuse Treatment, Prevention, and Policy 2011, 6:28 (18 October 2011)
The one new journal we might actually need
Genome Biology 2011, 12:129 (29 September 2011)
The one thing that I actually do want for Christmas: another scientific journal
Genome-wide examination of the transcriptional response to ecdysteroids 20-hydroxyecdysone and ponasterone A in Drosophila melanogaster
BMC Genomics 2011, 12:475 (29 September 2011)
Nothing to do and all day to do it in
Genome Biology 2011, 12:126 (31 August 2011)
The perfect end to a perfect vacation day
Food of the dogs
Genome Biology 2011, 12:122 (25 July 2011)
Human evolution and the Paleofood movement
Resource flows and levels of spending for the response to HIV and AIDS in Belarus
BMC Research Notes 2011, 4:248 (21 July 2011)
Genome Biology 2011, 12:119 (30 June 2011)
Greater risk in funding scientific research could lead to better results
In praise of model organisms
Genome Biology 2011, 12:115 (30 May 2011)
Basic research in model organisms is crucial and needs defending against claims that it is irrelevant to human biology and disease.
Functional connectivity in a rhythmic inhibitory circuit using Granger causality
Neural Systems & Circuits 2011, 1:9 (25 May 2011)
Granger causality is a useful analysis in the context of inhibitory coupling, but the relationship between GC results and actual synaptic strength becomes more complicated when the postsynaptic neurons have more complex intrinsic membrane properties.
The blue marble
Genome Biology 2011, 12:112 (28 April 2011)
A picture speaks a thousand words.
The walking dead
Genome Biology 2011, 12:108 (31 March 2011)
Creationism, academic freedom and funding: keeping the zombie out of science.
There is a sanity clause
Genome Biology 2011, 12:105 (25 February 2011)
Supply versus demand part II: will funding basic research lead to medical advances?
Preserving some sanity
Genome Biology 2011, 12:102 (31 January 2011)
Supply versus demand: can the focus on translational medicine deliver?
The effect of time of onset on community preferences for health states: an exploratory study
Health and Quality of Life Outcomes 2011, 9:6 (20 January 2011)
The long and the short of it
Genome Biology 2010, 11:145 (23 December 2010)
An end of year assessment of potential scientific investments.
Every dog has his day in court
Genome Biology 2010, 11:139 (30 November 2010)
The dog days of stem cell funding.
A Faustian bargain
Genome Biology 2010, 11:138 (31 October 2010)
An open letter to George M Philip, President of the State University of New York At Albany.
Shadows on the wall
Genome Biology 2010, 11:136 (23 September 2010)
Skepticism is healthy and the toppling of scientific paradigms shouldn’t be feared.
The past is a foreign country
Genome Biology 2010, 11:131 (27 August 2010)
The scientific worldview of someone starting graduate school today is very different from that of previous generations.
Condensation oscillations in the peptidization of phenylglycine
Journal of Systems Chemistry 2010, 1:7 (18 August 2010)
Correction to "Fixed Points of Maps of a Nonaspherical Wedge"
Fixed Point Theory and Applications 2010, 2010:820265 (8 August 2010)
When the pie is too small
Genome Biology 2010, 11:127 (30 July 2010)
The NIH science funding pie has many mouths to feed; can a little go a long way?
Genome Biology 2010, 11:124 (30 June 2010)
The genomics era Shelley, Craig Venter, has refocused attention on synthetic biology by creating a bacterium.
When failure should be the option
BMC Biology 2010, 8:61 (21 May 2010)
Most clinical trials for new drugs fail Phase II trials for efficacy. Gregory Petsko argues that such failures are a crucial resource for accelerating the development of new drugs for other targets.
And they said it wouldn't last...
Genome Biology 2010, 11:121 (5 May 2010)
In the 10 years that
Genome Biology has been published the scientific changes have been amazing, as have the changes in the culture of science.
The devil's in the details
Genome Biology 2010, 11:117 (30 April 2010)
The Cures Acceleration Network brought in by the US Health Care Reform Bill looks good but could take funding from other research.